Terray Therapeutics
Data as of .
Company facts
-
Founded
2018
-
Headquarters
United States (Monrovia, CA)
-
Total funding
$200M
Latest funding round
- Round
- Series B
- Date
- Oct 17, 2024
- Amount
- $120M
- Lead investor
- Bedford Ridge Capital and NVentures (NVIDIA)
Drug discovery partners
1 pharma. Pharma here means a company with approved products and roughly $1B or more in annual revenue.
-
Bristol Myers Squibb Pharma
Collaboration milestone,
Terms not disclosed
Big tech ties
Not counted as pharma partners.
-
NVIDIA (NVentures)
Investor (Series B co-lead)
Recent news
-
To speak at September 2026 investor conferences
-
Presents TerraBind, a co-folding potency model in its EMMI platform, at ICML
-
Reaches an AI-enabled discovery milestone in its Bristol Myers Squibb collaboration
-
Launches EMMI, an AI-native platform for de novo small molecule discovery
Confirmed means the company, a partner or a filing said it. Reported means a third party said it. This section sits outside the Pharma AI Tracker.
Spot an error? Tell me and I'll fix it.